1.同济大学附属上海市肺科医院(上海 200433)
2.苏州市中医医院(江苏 苏州 215000)
顾瞻,男,博士,主治医师,主要从事中西医结合防治肺系疾病临床与研究工作
王丽新,主任医师;E-mail:wlx1126@hotmail.com
扫 描 看 全 文
顾瞻,陆海雯,吴勇汇,等.慢性阻塞性肺疾病合并肺癌的中医证候要素分布规律研究[J].上海中医药杂志,2023,57(10):13-17.
GU Zhan,LU Haiwen,WU Yonghui,et al.Distribution rule of TCM syndrome elements in chronic obstructive pulmonary disease with lung cancer[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(10):13-17.
顾瞻,陆海雯,吴勇汇,等.慢性阻塞性肺疾病合并肺癌的中医证候要素分布规律研究[J].上海中医药杂志,2023,57(10):13-17. DOI: 10.16305/j.1007-1334.2023.2303085.
GU Zhan,LU Haiwen,WU Yonghui,et al.Distribution rule of TCM syndrome elements in chronic obstructive pulmonary disease with lung cancer[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(10):13-17. DOI: 10.16305/j.1007-1334.2023.2303085.
目的,2,研究慢性阻塞性肺疾病(COPD)合并肺癌的中医证候要素分布规律。,方法,2,参考相关文献内容结合临床实践经验,筛选出能够反映COPD和肺癌临床特征性变化的中医症状及体征并制定调查量表,在此基础上收集COPD(无肺癌)、肺癌(无COPD)、COPD合并肺癌患者(分别设为COPD组、肺癌组、COPD合并肺癌组)的基线资料及中医四诊信息,并录入“肺i中医”健康管理软件系统,结合证候要素辨证体系分析比较各组患者中医证候要素的分布情况。借助系统聚类分析方法探讨中医证候要素的组合规律。,结果,2,①共收集有效病例527例,其中COPD组166例、肺癌组182例、COPD合并肺癌组179例。②179例COPD合并肺癌患者的病性类中医证候要素中,超过1/3的患者有痰(134例)、气虚(123例)、血瘀(75例)。与COPD组相比,COPD合并肺癌组患者痰和血瘀出现比例增加,气滞出现比例减少(,P,<,0.05);与肺癌组相比,COPD合并肺癌组患者痰出现比例增加,阴虚出现比例减少(,P,<,0.05)。③179例COPD合并肺癌患者的病位类中医证候要素中,超过半数患者的病位涉及肺(179例)、肾(121例)、脾(94例)。与肺癌组相比,COPD合并肺癌组患者病位涉及肾的比例增加(,P,<,0.05)。④与COPD组、肺癌组比较,COPD合并肺癌组出现≥3个中医证候要素的患者比例增加(,P,<,0.05)。⑤COPD合并肺癌的病性类中医证候要素可聚为3大类:第一类为痰和血瘀,第二类为气虚和阳虚,第三类为阴虚、湿、热、血虚、气滞和寒。,结论,2,COPD合并肺癌的病位主要在肺、肾、脾,痰、血瘀、气虚、阳虚是最为常见的中医证候要素,具有正气不足、痰瘀互结、虚实夹杂的病机特点。
Objective,2,To explore the distribution rule of traditional Chinese medicine (TCM) syndrome elements in chronic obstructive pulmonary disease (COPD) with lung cancer.,Methods,2,Referring to relevant literature and clinical experience, the TCM symptoms and signs that can reflect the clinical characteristics of COPD and lung cancer were selected and a survey scale was developed. On this basis, baseline data and TCM four diagnosis information of COPD (without lung cancer), lung cancer (without COPD), and COPD with lung cancer (respectively set as COPD group, lung cancer group, and COPD with lung cancer group) were collected and entered into “iLUNG TCM” health management software system. The TCM syndrome elements distribution in each group of patients were analyzed and compared based on the syndrome elements differentiation system. The TCM syndrome elements combination rule was explored using hierarchical cluster analysis method.,Results,2,①A total of 527 subjects were collected, including 166 patients in the COPD group, 182 patients in the lung cancer group, and 179 patients in the COPD with lung cancer group. ②Among 179 patients in the COPD with lung cancer group, more than one-third had phlegm(134 cases), qi deficiency (123 cases), and blood stasis (75 cases) in terms of TCM syndrome elements of the disease nature category. The COPD with lung cancer group had higher proportion of patients with phlegm and blood stasis and lower proportion of patients with qi stagnation than the COPD group (,P,<,0.05); Meanwhile, the COPD with lung cancer group had higher proportion of patients with phlegm and lower proportion of patients with yin deficiency than the lung cancer group (,P,<,0.05). ③Among 179 patients in the COPD with lung cancer group, more than half of the patients had their disease locations involving the lung (179 cases), kidney (121 cases), and spleen (94 cases) in terms of the TCM syndrome elements of disease location category. The COPD with lung cancer group had higher proportion of kidney involvement in patients than the lung cancer group (,P,<,0.05). ④The COPD with lung cancer group had higher proportion of patients with more than 3 syndrome elements than the COPD group and the lung cancer group (,P,<,0.05). ⑤The result of cluster analysis showed that the syndrome elements of the disease nature category in COPD with lung cancer could be divided into three categories: the first category included phlegm and blood stasis, the second category included qi deficiency and yang deficiency, and the third category included yin deficiency, dampness, heat, blood deficiency, qi stagnation and cold.,Conclusions,2,The disease location of COPD with lung cancer is mainly in lung, kidney and spleen. The phlegm, blood stasis, qi deficiency and yang deficiency are the most common TCM syndrome elements in patients with COPD and lung cancer, with the pathogenic characteristics of vital qi deficiency, intermingled phlegm and blood stasis, and intermingled deficiency and excess.
慢性阻塞性肺疾病肺癌中医证候辨证论治中医病机炎-癌转化
chronic obstructive pulmonary diseaselung cancertraditional Chinese medicine syndromesyndrome differentiation and treatmentpathogenesis of traditional Chinese medicineinflammatory to cancerous transformation
FANG L, GAO P, BAO H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J]. Lancet Respir Med, 2018, 6(6): 421-430.
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
ZHAO G X, LI X L, LEI S Y, et al. Prevalence of lung cancer in chronic obstructive pulmonary disease: a systematic review and meta-analysis[J]. Front Oncol, 2022, 16(12): 947981.
BARREIRO E, BUSTAMANTE V, CURULL V, et al. Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights[J]. J Thorac Dis, 2016, 8(10): E1122-E1135.
TAKIGUCHI Y, SEKINE I, IWASAWA S, et al. Chronic obstructive pulmonary disease as a risk factor for lung cancer[J]. World J Clin Oncol, 2014, 5(4): 660-666.
赵思维,曹晓红. 慢性阻塞性肺疾病与肺癌相关的分子机制研究进展[J]. 临床肺科杂志,2021, 26(12): 1899-1902.
押丽静,白彦萍,李锘,等. 中医证素的研究概况[J]. 环球中医药,2019, 12(3): 459-463.
陶至立,陈慧娟. 数据挖掘在中医证候研究中的应用进展[J]. 上海中医药杂志,2021, 55(6): 91-95.
陈亚红. 2019年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版),2019, 11(1): 1-14.
中华医学会,中华医学会肿瘤学分会,中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2019版)[J]. 中华肿瘤杂志,2020, 42(4): 257-287.
李灿东,吴承玉. 中医诊断学[M]. 北京:中国中医药出版社,2012.
周仲瑛. 中医内科学[M]. 北京:中国中医药出版社,2017: 5-125.
朱文锋. 证素辨证学[M]. 北京:人民卫生出版社,2008: 162-228.
李建生. 正虚积损为慢性阻塞性肺疾病的主要病机[J]. 中华中医药杂志,2011, 26(8): 1710-1713.
黄牧华,董竞成,魏颖,等. 慢性阻塞性肺疾病中医证候及证素分布规律与特征的文献分析研究[J]. 中国中医基础医学杂志,2019, 25(10): 1373-1376.
刘嘉湘,陈树森,郁仁存,等. 肺癌证治[J]. 中医杂志,1986, 31(3): 4-7.
郭雯,冯贞贞,王露,等. 基于文献的肺癌常见中医证候研究[J]. 中医杂志,2021, 62(16): 1447-1454.
李娟,郭安,孙增涛. 从气虚阳微、痰瘀交阻论治原发性支气管肺癌[J]. 中医杂志,2022, 63(5): 491-493.
朱文锋. 证素辨证研究钩玄[J]. 河南中医,2009, 29(1): 1-4.
朱文锋,甘慧娟. 证素内容的辨析[J]. 中医药导报,2005, 11(1): 11-13.
田建辉,罗斌,阙祖俊,等. 癌症转移亚临床阶段核心病机“正虚伏毒”学说[J]. 上海中医药杂志,2021, 55(10): 1-3, 13.
程海波,沈卫星. 癌毒病机理论与炎癌转变[J]. 中国中西医结合杂志,2015, 35(2): 243-246.
唐振豪,兰聪颖,林丽珠. 从肿瘤免疫编辑假说探讨肿瘤“正虚邪实”及其治疗[J]. 中医杂志,2019, 60(13): 1113-1117.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构